Inventor · disambiguated record
Timothy B. Lowinger
Also filed as: LOWINGER TIMOTHY · LOWINGER TIMOTHY B · LOWINGER TIMOTHY P
53 granted patents·51 pending applications·999 citations·filing 1998–2025
99Inventor score
Top patents by PatentIndex Score
104 records- 0198US8815226B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2012·Granted Aug 26, 2014·54 cites·8 claims
- 0297US9144615B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2014·Granted Sep 29, 2015·19 cites·22 claims
- 0397US8821850B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2014·Granted Sep 2, 2014·20 cites·18 claims
- 0497US7235576B1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Jun 26, 2007·94 cites·47 claims
- 0596US9738720B2Monoclonal antibodies against HER2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·10 cites·30 claims
- 0696US8349308B2Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2011·Granted Jan 8, 2013·141 cites·31 claims
- 0796US7897623B2ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitorsBAYER HEALTHCARE LLC·Filed 2007·Granted Mar 1, 2011·35 cites·8 claims
- 0896US7625915B2Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER HEALTHCARE LLC·Filed 2007·Granted Dec 1, 2009·33 cites·1 claims
- 0996US7528255B2Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted May 5, 2009·35 cites·15 claims
- 1096US7351834B1ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Apr 1, 2008·64 cites·41 claims
- 1195US8808679B2Auristatin compounds and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2013·Granted Aug 19, 2014·26 cites·20 claims
- 1295US8685383B2Protein-polymer-drug conjugatesYURKOVETSKIY ALEKSANDR·Filed 2012·Granted Apr 1, 2014·38 cites·9 claims
- 1394US10947317B2NaPi2b-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2017·Granted Mar 16, 2021·9 cites·15 claims
- 1494US9555112B2Monoclonal antibodies against HER2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2015·Granted Jan 31, 2017·13 cites·42 claims
- 1594US8841330B2Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsRIEDL BERND·Filed 2012·Granted Sep 23, 2014·12 cites·14 claims
- 1694US7329670B1Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER PHARMACEUTICALS CORP·Filed 1999·Granted Feb 12, 2008·76 cites·7 claims
- 1793US10143695B2Pyrrolobenzodiazepines and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·7 cites·25 claims
- 1893US9254339B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2014·Granted Feb 9, 2016·16 cites·20 claims
- 1992US12156870B2Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2022·Granted Dec 3, 2024·1 cites·30 claims
- 2092US9770519B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2015·Granted Sep 26, 2017·2 cites·21 claims
- 2192US8124630B2ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsRIEDL BERND·Filed 2001·Granted Feb 28, 2012·27 cites·16 claims
- 2291US8524214B2Polyal drug conjugates comprising variable rate-releasing linkersYURKOVETSKIY ALEKSANDR·Filed 2010·Granted Sep 3, 2013·33 cites·30 claims
- 2389US11135307B2Peptide-containing linkers for antibody-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2017·Granted Oct 5, 2021·4 cites·8 claims
- 2489US2025066489A1Monoclonal antibodies against her2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2587US6562811B1Pyridine derivativesBAYER AG·Filed 2001·Granted May 13, 2003·29 cites·12 claims
- 2686US10660901B2Pyrrolobenzodiazepines and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2018·Granted May 26, 2020·2 cites·25 claims
- 2786US7517880B2Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Apr 14, 2009·25 cites·21 claims
- 2885US10603386B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2017·Granted Mar 31, 2020·1 cites·18 claims
- 2984US11434278B2Protein-polymer-drug conjugatesASANA BIOSCIENCES LLC·Filed 2019·Granted Sep 6, 2022·1 cites·4 claims
- 3084US7928239B2Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER HEALTHCARE LLC·Filed 2001·Granted Apr 19, 2011·15 cites·18 claims
- 3184US6911443B2Imidazopyrimidine derivatives and triazolopyrimidine derivativesBAYER AG·Filed 2001·Granted Jun 28, 2005·32 cites·7 claims
- 3283US10526294B2Pyrrolobenzodiazepines and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2017·Granted Jan 7, 2020·5 cites·29 claims
- 3382US10316080B2Protein-polymer-drug conjugatesASANA BIOSCIENCES LLC·Filed 2014·Granted Jun 11, 2019·4 cites·4 claims
- 3482US2023265197A1Monoclonal antibodies against her2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3581US7700586B2Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disordersAXIKIN PHARMACEUTICALS INC·Filed 2002·Granted Apr 20, 2010·19 cites·19 claims
- 3681US6541468B1Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancerBAYER AG·Filed 1999·Granted Apr 1, 2003·44 cites·6 claims
- 3780US12440576B2Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2022·Granted Oct 14, 2025·0 cites·20 claims
- 3880US9808528B2Protein-polymer-drug conjugates and methods of using sameMERSANA THERAPEUTICS INC·Filed 2015·Granted Nov 7, 2017·2 cites·20 claims
- 3980US2025352662A1Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4079US9943609B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2016·Granted Apr 17, 2018·2 cites·20 claims
- 4178US9849191B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2014·Granted Dec 26, 2017·3 cites·19 claims
- 4278US2024382611A1Peptide-containing linkers for antibody-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4377US10226535B2Auristatin compounds and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2013·Granted Mar 12, 2019·2 cites·19 claims
- 4475US6984649B1Pyridine derivativesBAYER AG·Filed 2003·Granted Jan 10, 2006·7 cites·12 claims
- 4575US6013646AIndolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancerBAYER AG·Filed 1998·Granted Jan 11, 2000·33 cites·14 claims
- 4674US11518812B2Monoclonal antibodies against HER2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2019·Granted Dec 6, 2022·0 cites·14 claims
- 4774US10772971B2Methods of producing drug-carrying polymer scaffolds and protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2018·Granted Sep 15, 2020·1 cites·41 claims
- 4874US2023183326A1Protein-polymer-drug conjugatesASANA BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 4972US2024148887A1Site specific antibody-drug conjugates with peptide-containing linkersMERSANA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 5071US7232909B2Pyridine derivativesBAYER AG·Filed 2005·Granted Jun 19, 2007·1 cites·5 claims
Showing the top 50 of 104 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →